Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • How big is the problem?
    • How we drive change
    • Our story
  • Featured insights
    • The latest at the Foundation
    • The latest at the Foundation
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • Become a catalyst
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
  • Achievements so far
    • The Foundation's impact
    • The Foundation's impact
  • News
  • Our team
  • Our impact
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us
Photo of: Fatima Suleman
MEMBER OF THE EXPERT COMMITTEE FOR THE GENERIC MEDICINE MANUFACTURERS RESEARCH PROGRAMME

Fatima Suleman

Dr Fatima Suleman is a member of the 2022 Expert Review Committee for the Generic Medicine Manufacturers Research Programme. She is also a member of the 2022 Expert Review Committee for the Access to Medicine Index.

Dr Suleman is a Professor in the School of Health Sciences, University of KwaZulu-Natal and Professor, and Director of the World Health Organization Collaborating Centre for Pharmaceutical Policy and Evidence Based Practice. She is a former Prince Claus Chair of Development and Equity: Affordable (Bio)Therapeutics for Public Health (until September 2018) at Utrecht University, and a Fulbright Alumnus (Fulbright Scholar 2002-2004). She was appointed by the South African Minister of Health to serve on the National Pricing Committee (2010-2020). 

Dr Suleman has been appointed to the World Health Organization's Expert Advisory Panel on Drug Evaluation (2017 - 2021). She is an EXCO member for the African Forum on Research and Education in Health (AFREhealth) PI Council (current). She has served on a number of WHO committees over the years and been a technical advisor on pharmaceutical policy for a number of countries. She has a number of publications in the area of pharmaceutical policy and medicine use.

The Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Copyright 2004 - 2022 Access to Medicine Foundation - All Rights Reserved